Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-21-009368

General Counsel sold 90,000 shares at an average $88.46 ($7,961,240)

  • General Counsel acquired 90,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
O'Brien Patrick General Counsel 2021-02-08 Option exercise +90,000 $5.22 $469,800 383,375 D
O'Brien Patrick General Counsel 2021-02-08 Sale −7,961 $86.72 $690,378 375,414 D
O'Brien Patrick General Counsel 2021-02-08 Sale −31,255 $88.08 $2,752,940 344,159 D
O'Brien Patrick General Counsel 2021-02-08 Sale −45,348 $88.88 $4,030,530 298,811 D
O'Brien Patrick General Counsel 2021-02-08 Sale −5,436 $89.66 $487,392 293,375 D
Derivatives
O'Brien Patrick General Counsel 2021-02-08 Option exercise · Stock Option (right to buy) −90,000 60,000 D
Open-market sales · 90,000 sh · avg $88.46 · $7,961,240
Loading xslF345X03/doc4.xml…